Loading...
Pembrolizumab
India Pharmaceutical Trade Intelligence
Who Supplies Pembrolizumab to India from SINGAPORE
India's pembrolizumab imports from SINGAPORE total $85.8M across 9 shipments from 1 foreign suppliers. MERCK SHARP & DOHME ASIA PACIFIC SERVICES PTE LTD, leads with $85.8M in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include MSD PHARMACEUTICALS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for pembrolizumab — a concentrated sourcing relationship with select suppliers from SINGAPORE.
Top foreign suppliers (SINGAPORE) — Ranked by import value
MERCK SHARP & DOHME ASIA PACIFIC SERVICES PTE LTD, is the leading Pembrolizumab supplier from SINGAPORE to India, with import value of $85.8M across 9 shipments. The top 5 suppliers — MERCK SHARP & DOHME ASIA PACIFIC SERVICES PTE LTD, — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (SINGAPORE)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MERCK SHARP & DOHME ASIA PACIFIC SERVICES PTE LTD, | $85.8M | 9 | 100.0% |
Showing top 1 of 1 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from SINGAPORE)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MSD PHARMACEUTICALS PRIVATE LIMITED | $85.8M | 9 | 100.0% |
Import Statistics
- Import Value
- $85.8M
- Shipments
- 9
- Foreign Suppliers
- 1
- Indian Buyers
- 1
- Avg. Shipment
- $9.5M
Other Pembrolizumab Import Origins
Related Analysis
Frequently Asked Questions — Pembrolizumab Imports from SINGAPORE
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Pembrolizumab suppliers from SINGAPORE to India?
The top Pembrolizumab suppliers from SINGAPORE to India include MERCK SHARP & DOHME ASIA PACIFIC SERVICES PTE LTD,. The leading supplier is MERCK SHARP & DOHME ASIA PACIFIC SERVICES PTE LTD, with import value of $85.8M USD across 9 shipments. India imported Pembrolizumab worth $85.8M USD from SINGAPORE in total across 9 shipments.
QHow much Pembrolizumab does India import from SINGAPORE?
India imported Pembrolizumab worth $85.8M USD from SINGAPORE across 9 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Pembrolizumab from SINGAPORE?
The main Indian buyers of Pembrolizumab sourced from SINGAPORE include MSD PHARMACEUTICALS PRIVATE LIMITED. The largest buyer is MSD PHARMACEUTICALS PRIVATE LIMITED with $85.8M in imports across 9 shipments.
QWhat is the total value of Pembrolizumab imports from SINGAPORE to India?
The total value of Pembrolizumab imports from SINGAPORE to India is $85.8M USD, across 9 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: SINGAPORE to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Pembrolizumab.
- 2.Supplier/Buyer Matching: 1 foreign suppliers from SINGAPORE and 1 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $85.8M aggregated from 9 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
9 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists